Diagnostic Approach to Inflammatory Bowel Disease

Initial Laboratory Investigations

The European Crohn's and Colitis Organisation recommends complete blood count (CBC) to check for anemia, a common complication of IBD, in patients with suspected inflammatory bowel disease 1, 2
The American Gastroenterological Association suggests C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR) as important inflammatory markers that can indicate active disease, though approximately 20% of patients with active Crohn's disease may have normal CRP levels 1, 3
The British Society of Gastroenterology recommends liver function tests and electrolytes (U&Es) as part of the initial workup for patients with suspected IBD 1
Stool tests for infectious pathogens, including Clostridium difficile toxin, are essential to exclude infectious causes of diarrhea that can mimic IBD, as recommended by the Infectious Diseases Society of America 1, 2
Fecal calprotectin and fecal lactoferrin are highly sensitive non-invasive biomarkers that can help differentiate IBD from irritable bowel syndrome (IBS) with sensitivity of 93% and specificity of 96% in adults, according to the American College of Gastroenterology 3

The European Crohn's and Colitis Organisation states that pANCA (perinuclear anti-neutrophil cytoplasmic antibodies) and ASCAs (anti-Saccharomyces cerevisiae antibodies) may be used to support a diagnosis, though their accuracy is limited and they are ineffective at differentiating colonic Crohn's from ulcerative colitis 2, 4
Antiglycan and antimicrobial antibodies (such as anti-OmpC and CBir1) provide minimal additional diagnostic value, as reported by the American Gastroenterological Association 2
The British Society of Gastroenterology recommends against genetic testing for IBD-associated susceptibility single nucleotide polymorphisms (SNPs) for diagnosis, despite identification of over 250 IBD-associated variants 2

The American College of Gastroenterology recommends interpreting serum ferritin levels in the context of inflammation status, with serum ferritin <30 μg/L indicating iron deficiency in patients without evidence of active disease, and serum ferritin up to 100 μg/L potentially indicating iron deficiency in patients with inflammation 2
The European Crohn's and Colitis Organisation suggests that serum ferritin >100 μg/L and transferrin saturation <20% indicates anemia of chronic disease in patients with biochemical evidence of inflammation 2

The American Gastroenterological Association recommends that laboratory tests alone cannot diagnose IBD or Crohn's disease - they must be interpreted alongside endoscopic findings, imaging, and histology 1, 2
Ileocolonoscopy with biopsies remains the gold standard procedure for diagnosing IBD, allowing direct visualization of the mucosa and collection of tissue samples, as recommended by the British Society of Gastroenterology 2, 4
The European Crohn's and Colitis Organisation suggests that cross-sectional imaging (CT enterography, MR enterography, or ultrasound) is necessary to assess the extent and severity of disease, particularly for evaluating small bowel involvement in Crohn's disease 3, 5
Small bowel capsule endoscopy may be useful in cases where other investigations are inconclusive, but should be preceded by cross-sectional imaging or patency capsule to avoid capsule retention in patients with suspected strictures, as recommended by the American College of Gastroenterology 6, 7

Relying solely on laboratory markers for diagnosis can lead to misdiagnosis, as no single test is specific or sensitive enough for IBD, as reported by the American Gastroenterological Association 1, 2
Normal CRP does not exclude active disease, as approximately 20% of patients with active Crohn's disease may have normal CRP levels, according to the European Crohn's and Colitis Organisation 3
Failure to exclude infectious causes before making an IBD diagnosis can lead to inappropriate treatment, as recommended by the Infectious Diseases Society of America 1, 2
Interpreting iron studies without considering the impact of inflammation can lead to missed iron deficiency diagnosis, as suggested by the British Society of Gastroenterology 2
Using serological markers (pANCA, ASCAs) alone to differentiate between Crohn's disease and ulcerative colitis is unreliable, as reported by the American Gastroenterological Association 2